nelarabine

FDA Drug Profile — Arranon, NELARABINE, nelarabine

nelarabine is listed in the FDA National Drug Code directory with 7 NDC codes, marketed under brand names including Arranon, NELARABINE, nelarabine. Available dosage forms: injection, powder.

Drug details

Generic Name
nelarabine
Brand Names
Arranon, NELARABINE, nelarabine
Application Number
NDA021877
Sponsor
Novartis Pharmaceuticals Corporation
NDC Codes
7
Dosage Forms
INJECTION, POWDER
Routes
INTRAVENOUS
Active Ingredients
NELARABINE

Indications and Usage

1 INDICATIONS AND USAGE Nelarabine injection is indicated for the treatment of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in adult and pediatric patients age 1 year and older whose disease has not responded to or has relapsed following treatment with at least 2 chemotherapy regimens. Nelarabine is a nucleoside metabolic inhibitor indicated for the treatment of patients with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in adult and pediatric patients age 1 year and older whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.